Literature DB >> 9785052

The familial chylomicronemia syndrome.

S Santamarina-Fojo1.   

Abstract

The chylomicronemia syndrome is a disorder characterized by severe hypertriglyceridemia and fasting chylomicronemia. Genetic causes of the syndrome are rare and include deficiency of lipoprotein lipase (LPL), apolipoprotein C-II, and familial inhibitor of LPL. Patients with familial forms of hypertriglyceridemia in combination with secondary acquired disorders account for most individuals presenting with chylomicronemia. The clinical manifestations--lipid and other biochemical abnormalities--as well as treatment options for chylomicronemic patients are discussed.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9785052     DOI: 10.1016/s0889-8529(05)70025-6

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  31 in total

Review 1.  Monogenic dyslipidemias: window on determinants of plasma lipoprotein metabolism.

Authors:  R A Hegele
Journal:  Am J Hum Genet       Date:  2001-10-26       Impact factor: 11.025

Review 2.  Endothelial lipase: direct evidence for a role in HDL metabolism.

Authors:  Jonathan C Cohen
Journal:  J Clin Invest       Date:  2003-02       Impact factor: 14.808

3.  Severe hypertriglyceridemia-induced pancreatitis during pregnancy.

Authors:  Alptekin Gürsoy; Mustafa Kulaksizoglu; Mustafa Sahin; Derun Taner Ertugrul; Feyza Ozer; Neslihan Bascil Tutuncu; Nilgun Guvener Demirag
Journal:  J Natl Med Assoc       Date:  2006-04       Impact factor: 1.798

4.  Apelin decreases lipolysis via G(q), G(i), and AMPK-Dependent Mechanisms.

Authors:  Patrick Yue; Hong Jin; Shiming Xu; Marissa Aillaud; Alicia C Deng; Junya Azuma; Ramendra K Kundu; Gerald M Reaven; Thomas Quertermous; Philip S Tsao
Journal:  Endocrinology       Date:  2010-11-03       Impact factor: 4.736

Review 5.  Emerging strategies of targeting lipoprotein lipase for metabolic and cardiovascular diseases.

Authors:  Werner J Geldenhuys; Li Lin; Altaf S Darvesh; Prabodh Sadana
Journal:  Drug Discov Today       Date:  2016-10-19       Impact factor: 7.851

6.  Impact of lipoprotein lipase gene polymorphisms on ulcerative colitis.

Authors:  Toshihito Kosaka; Junji Yoshino; Kazuo Inui; Takao Wakabayashi; Kazumu Okushima; Takashi Kobayashi; Hironao Miyoshi; Yuta Nakamura; Shigekazu Hayashi; Taizou Shiraishi; Masatoshi Watanabe; Takayuki Yamamoto; Ai Nakahara; Takahiko Katoh
Journal:  World J Gastroenterol       Date:  2006-10-21       Impact factor: 5.742

7.  Identifying suspected familial chylomicronemia syndrome.

Authors:  Ronak Rengarajan; Peter A McCullough; Anima Chowdhury; Kristen M Tecson
Journal:  Proc (Bayl Univ Med Cent)       Date:  2018-05-21

8.  Triglycerides and cardiovascular risk.

Authors:  K E L Harchaoui; M E Visser; J J P Kastelein; E S Stroes; G M Dallinga-Thie
Journal:  Curr Cardiol Rev       Date:  2009-08

Review 9.  Lipoprotein disorders and cardiovascular risk.

Authors:  J Genest
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

10.  Lipoprotein lipase activity and mass, apolipoprotein C-II mass and polymorphisms of apolipoproteins E and A5 in subjects with prior acute hypertriglyceridaemic pancreatitis.

Authors:  Inmaculada Coca-Prieto; Pedro Valdivielso; Gunilla Olivecrona; María José Ariza; José Rioja; Pilar Font-Ugalde; Carlota García-Arias; Pedro González-Santos
Journal:  BMC Gastroenterol       Date:  2009-06-17       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.